EXPERIMENTAL APPROACHES FOR THE TREATMENT OF MURINE B16 MELANOMAS OF VARIOUS SIZES .2. INJECTION OF ETHANOL WITH COMBINATIONS OF INTERFERON-BETA AND MICROWAVAL HYPERTHERMIA FOR B16 MELANOMAS WITH A SIZE OF GREATER-THAN 10 MM IN DIAMETER

Citation
J. Nakayama et al., EXPERIMENTAL APPROACHES FOR THE TREATMENT OF MURINE B16 MELANOMAS OF VARIOUS SIZES .2. INJECTION OF ETHANOL WITH COMBINATIONS OF INTERFERON-BETA AND MICROWAVAL HYPERTHERMIA FOR B16 MELANOMAS WITH A SIZE OF GREATER-THAN 10 MM IN DIAMETER, Journal of dermatological science, 15(2), 1997, pp. 82-88
Citations number
7
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
09231811
Volume
15
Issue
2
Year of publication
1997
Pages
82 - 88
Database
ISI
SICI code
0923-1811(1997)15:2<82:EAFTTO>2.0.ZU;2-8
Abstract
Although ethanol injection in combination with microwaval hyperthermia and systemic administration of interleukin-2 was found to be very eff ective in suppressing the growth of B16 melanoma nodules with a size o f less than 7 mm in diameter in our previous experiments, the growth o f B16 melanomas with a size of greater than 10 mm in diameter was very difficult to control with any of the therapeutic modalities examined. In subsequent experiments, we investigated whether ethanol injection (150 mu l/injection) in combination with local injection of beta-inter feron (2 x 10(4) IU/injection) and local microwaval hyperthermia al 43 degrees C for 15 min was able to suppress the growth of melanoma nodu les and to prolong survival times of melanoma-burdened mice. The resul ts were that we successfully suppressed the growth of melanoma nodules of that size for the first time with combinations of the therapeutic modalities described above. Infiltration of immunocompetent cells such as T lymphocytes and NK cells was clearly observed In the melanoma ti ssues treated with the therapeutic combination. These experimental res ults should be applied to the treatment of human melanomas in advanced stages which have no indications for surgical operation. (C) 1997 Els evier Science Ireland Ltd.